Stock 603392 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Equities

603392

CNE100004090

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
68.26 CNY +7.67% Intraday chart for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. +2.31% -9.14%
04-25 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-12 Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected' MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected'
MT
Wantai BioPharm's 2023 Profit Drops 74% on Revenue Drop; Shares Slump 3%
MT
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Wantai Biological Pharmacy Predicts Up to 75% Profit Decline in 2023
MT
Sinovac Halts Production of COVID-19 Vaccine as Demand Wanes
MT
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China
MT
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.
CI
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. authorizes a Buyback Plan.
CI
Wantai Biological Pharmacy's Profit Drops 36.8% in H1
MT
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Wantai Biological Pharmacy’s Profit Slides 6.5% in Q1 as Revenue Falls 9%
MT
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Wantai BioPharm Enrolls First Subjects for Pneumonia Vaccine Trial
MT
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.
CI
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback announced on August 6, 2022, has expired with 1,585,320 shares, representing 0.17% for CNY 200.17 million.
CI
China's super-rich see fortunes plunge as economy slows
RE
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603392 Stock
  4. News Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.